Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: Androgen deprivation therapy (ADT) is associated with increased fracture risk. In a recent Phase III trial, toremifene significantly decreased vertebral fractures in men receiving ADT. Similar to other selective estrogen receptor modulators, toremifene was associated with an increase in ven...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Smith, Matthew R., Malkowicz, S. Bruce, Brawer, Michael K., Hancock, Michael L., Morton, Ronald A., Steiner, Mitchell S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671875/
https://ncbi.nlm.nih.gov/pubmed/22014807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2011.07.090
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia